These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4152361)

  • 1. Proceedings: Non-specific cardiodepressant effects and hydrophobicity of two series of beta-adrenergic blocking drugs: influence of ring-alkylation and of n-alkylation.
    Hellenbrecht D; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R31. PubMed ID: 4152361
    [No Abstract]   [Full Text] [Related]  

  • 2. Excitatory and depressant effects of beta-adrenoceptor blocking agents on skeletal muscle.
    Wislicki L
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):310-7. PubMed ID: 4391894
    [No Abstract]   [Full Text] [Related]  

  • 3. [Actual knowledge on beta blocking agents in psychiatry (author's transl)].
    Scharbach H
    Acta Psychiatr Belg; 1978; 78(2):358-73. PubMed ID: 27946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between hydrophobicity and non-specific pharmacological effects of beta-adrenoceptor blocking agents.
    Hellenbrecht D; Gortner L
    Pol J Pharmacol Pharm; 1976; 28(6):625-30. PubMed ID: 13353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local anaesthetic and myocardial depressant effects of beta adrenoceptor blocking agents.
    Singh KP
    Indian J Physiol Pharmacol; 1980; 24(2):161-2. PubMed ID: 6103869
    [No Abstract]   [Full Text] [Related]  

  • 6. Some guanidine esters and their possible relationship to the action of tetrodotoxin.
    Fuhrman FA; Ranney BK; Schmiegel JL; Mosher H
    Proc West Pharmacol Soc; 1968; 11():37-9. PubMed ID: 4309293
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of -adrenoreceptor blocking drugs on isolated skeletal and cardiac muscle.
    Harry JD; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Oct; 43(2):453P-454P. PubMed ID: 4400575
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative structure-activity studies of beta-adrenoceptor blocking drugs to decrease ventricular arrhythmias in guinea pigs.
    Gortner L; Hellenbrecht D
    Arzneimittelforschung; 1988 Dec; 38(12):1796-9. PubMed ID: 2907727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative structure activity relationships of phenylakylamines. 2. Discrimination analysis of adrenergic alpha, anti-arrhythmic and cardiodepressive effects of beta receptor blockers (proceedings)].
    Bercher H; Laass W; Schult E; Grisk A; Franke R
    Pharmazie; 1979; 34(5-6):336-7. PubMed ID: 42092
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacology of the adrenergic system. 3. Interaction of drugs with adrenergic receptors].
    Ariëns EJ
    Pharm Weekbl; 1970 Dec; 105(49):1393-425. PubMed ID: 4395757
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Pharmacological studies with LL 21-945, a new beta-adrenoceptor blocking agent with a long duration of action.
    Clark BJ; Saameli K; Troxler F
    Br J Pharmacol; 1974 Sep; 52(1):123P. PubMed ID: 4155983
    [No Abstract]   [Full Text] [Related]  

  • 12. [Structure activity relationship in a series of new amino-halogen substituted phenyl-aminoethanols].
    Engelhardt G
    Arzneimittelforschung; 1972 May; 22(5):869-76. PubMed ID: 4403126
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: Influence of beta blocking agents on cardiac function and myocardial oxygen consumption in the isolated supported heart preparation of the dog.
    Kumakura S; Nishino H; Oshima T
    Jpn J Pharmacol; 1974; 24(0):s:72. PubMed ID: 4151685
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the combined use of beta-adrenergic blockade and antiarrhythmic drugs.
    Mazurowa A; Szadowska A; Szmigielski A; Litwinowicz A
    Arch Immunol Ther Exp (Warsz); 1970; 18(2):280-7. PubMed ID: 4393014
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacology of beta blockers].
    Pérez-Olea J
    Rev Med Chil; 1982 Aug; 110(8):774-83. PubMed ID: 6130591
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of some beta-adrenoceptor blocking agents on skeletal muscle.
    Jindal MN; Shah UH; Patel VK; Kelkar VV
    Arzneimittelforschung; 1975 Jan; 25(1):52-5. PubMed ID: 238544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of beta-adrenoceptor antagonists on acetylcholine concentration of mouse brain.
    Khanna NK; Madan BR
    Indian J Med Res; 1973 Jul; 61(7):1062-5. PubMed ID: 4148415
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and pharmacological activity of some 1-alkylamino-3-(2'-methoxy-4'-diethylcarbamoyl-phenoxy)propan-2-ols.
    Monforte P; Basile M; Previtera T; Larizza A; Marmo E; De Gennaro G; Montinaro C; Filippelli W; Montanaro CS; Marfella A; Larizza D
    Farmaco Sci; 1983 Mar; 28(3):173-86. PubMed ID: 6133779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective beta receptor blocking properties of DL-1-(2-acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane HC1 (M & B 17803-A) in the anesthetized dog.
    Levy B
    J Pharmacol Exp Ther; 1973 Jul; 186(1):134-44. PubMed ID: 4146701
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium.
    Gibson JK; Gelband H; Bassett AL
    J Pharmacol Exp Ther; 1977 Sep; 202(3):702-10. PubMed ID: 19621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.